Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gerritsen

Showing results (101-110 of 224) with videos related to

Pageof 23
Sort By:
British Journal of Cancer|July 31, 2003
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenograftsB Geoerger, J Grill, P Opolon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 24, 2021
Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the LiteratureJorien B E Janssen, Theresa Y S Leow, Karin H Herbschleb, et al.
British Journal of Cancer|March 5, 2002
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrugM de Graaf, E Boven, D Oosterhoff, et al.
The Journal of Gene Medicine|January 15, 2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastomaBirgit Geoerger, Victor W van Beusechem, Paule Opolon, et al.
Clinical Nuclear Medicine|November 23, 2017
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily PracticeMaarten J van der Doelen, Malou C P Kuppen, Marianne A Jonker, et al.
Gene Therapy|April 22, 2005
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyT Würdinger, M H Verheije, M Raaben, et al.
Clinical Genitourinary Cancer|May 11, 2013
Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the NetherlandsMichel D Wissing, Inge M van Oort, Winald R Gerritsen, et al.
Genes and Immunity|February 5, 2011
Severe combined immunodeficiency in Frisian Water Dogs caused by a RAG1 mutationB Verfuurden, F Wempe, P Reinink, et al.
Frontiers in Immunology|May 17, 2014
Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigensHarm Westdorp, Annette E Sköld, Berit A Snijer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vectorB W Tillman, T D de Gruijl, S A Luykx-de Bakker, et al.
Pageof 23

Showing results (101-110 of 224) with videos related to

Sort By:
Pageof 23
British Journal of Cancer|July 31, 2003
Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenograftsB Geoerger, J Grill, P Opolon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 24, 2021
Immune Checkpoint Inhibitor-related Guillain-Barré Syndrome: A Case Series and Review of the LiteratureJorien B E Janssen, Theresa Y S Leow, Karin H Herbschleb, et al.
British Journal of Cancer|March 5, 2002
A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrugM de Graaf, E Boven, D Oosterhoff, et al.
The Journal of Gene Medicine|January 15, 2005
Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastomaBirgit Geoerger, Victor W van Beusechem, Paule Opolon, et al.
Clinical Nuclear Medicine|November 23, 2017
223Ra Therapy in Patients With Advanced Castration-Resistant Prostate Cancer With Bone Metastases: Lessons from Daily PracticeMaarten J van der Doelen, Malou C P Kuppen, Marianne A Jonker, et al.
Gene Therapy|April 22, 2005
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyT Würdinger, M H Verheije, M Raaben, et al.
Clinical Genitourinary Cancer|May 11, 2013
Cabazitaxel in patients with metastatic castration-resistant prostate cancer: results of a compassionate use program in the NetherlandsMichel D Wissing, Inge M van Oort, Winald R Gerritsen, et al.
Genes and Immunity|February 5, 2011
Severe combined immunodeficiency in Frisian Water Dogs caused by a RAG1 mutationB Verfuurden, F Wempe, P Reinink, et al.
Frontiers in Immunology|May 17, 2014
Immunotherapy for prostate cancer: lessons from responses to tumor-associated antigensHarm Westdorp, Annette E Sköld, Berit A Snijer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 3, 1999
Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vectorB W Tillman, T D de Gruijl, S A Luykx-de Bakker, et al.
Pageof 23